Pieris pharmaceuticals investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of pieris pharmaceuticals, inc. - pirs

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of pieris pharmaceuticals, inc. (nasdaqcm: pirs) (the “company”) and palvella therapeutics, inc. upon completion of the proposed transaction, pieris shareholders are expected to own approximately 18% of the combined company. ksf is seeking to determine whether the merger and the process that led to it are adequ.
GM Ratings Summary
GM Quant Ranking